The effect of component of microemulsion for transdermal delivery of nicardipine hydrochloride

Drug Development and Industrial Pharmacy

Volumn 36, Issue 12, 2010, Pages 1398-1403

  Wu, Pao Chu ^a   Lin, Yei Huan ^a   Chang, Jui Sheng ^a   Huang, Yaw Bin ^a   Tsai, Yi Hung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Flux; In vitro study; Microemulsion; Nicardipine hydrochloride; Transdermal delivery

Indexed keywords

ALCOHOL; MYRISTIC ACID ISOPROPYL ESTER; NICARDIPINE; POLYSORBATE 80; SORBITAN OLEATE; SURFACTANT;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TRANSPORT; MICROEMULSION; NONHUMAN; PARTICLE SIZE; RAT; SKIN PERMEABILITY; TITRIMETRY; TRANSDERMAL DRUG ADMINISTRATION;

ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; DRUG DELIVERY SYSTEMS; EMULSIONS; HEXOSES; MYRISTATES; NICARDIPINE; PARTICLE SIZE; PERMEABILITY; POLYSORBATES; RATS; SKIN ABSORPTION; SOLUBILITY; SURFACE-ACTIVE AGENTS; VASODILATOR AGENTS;

EID: 78149364021     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.485277     Document Type: Article

References (27)

1. Graham DJ, Dow RJ, Hall DJ, Alexander OF, Mroszczak EJ, Freedman D. (1985). The metabolism and pharmacokinetics of nicardipine hydrochloride in man. Br J Clin Pharmacol, 20(Suppl. 1):23S-8S.
2. Rush WR, Alexander O, Hall DJ, Cairncross L, Dow RJ, Graham DJ. (1986). The metabolism of nicardipine hydrochloride in healthy male volunteers. Xenobiotica, 16:341-49.
3. Campbell BC, Kelman AW, Hillis WS. (1985). Noninvasive assessment of the haemodynamic effects of nicardipine in normotensive subjects. Br J Clin Pharmacol, 20(Suppl. 1):55S-61S.
4. Cook E, Clifton GG, Vargas R, Bienvenu G, Williams R, Sambol N, et al. (1990). Pharmacokinetics, pharmacodynamics, and minimum effective clinical dose of intravenous nicardipine. Clin Pharmacol Ther, 47:706-18.
5. Sorkin EM, Clissold SP. (1987). Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drugs, 33:296-345.
6. Lambert WJ, Higuchi WI, Knutson K, Krill SL. (1989). Dosedependent enhancement effects of azone on skin permeability. Pharm Res, 6:798-803.
7. Chang JS, Huang YB, Hou SS, Wang RJ, Wu PC, Tsai YH. (2007). Formulation optimization of meloxicam sodium gel using response surface methodology. Int J Pharm, 338:48-54.
8. Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A. (2003). Microemulsions for topical delivery of estradiol. Int J Pharm, 254:99-107.
9. Liu H, Li S, Wang Y, Han F, Dong Y. (2006). Bicontinuous water-AOT/Tween85-isopropyl myristate microemulsion: A new vehicle for transdermal delivery of cyclosporin A. Drug Dev Ind Pharm, 32:549-57.
10. Huang YB, Lin YH, Lu TM, Wang RJ, Tsai YH, Wu PC. (2008). Transdermal delivery of capsaicin derivative-sodium nonivamide acetate using microemulsions as vehicles. Int J Pharm, 349:206-11.
11. Shevachman M, Garti N, Shani A, Sintov AC. (2008). Enhanced percutaneous permeability of diclofenac using a new U-type dilutable microemulsion. Drug Dev Ind Pharm, 34:403-12.
12. Wu H, Lu C, Zhou A, Min Z, Zhang Y. (2009). Enhanced oral bioavailability of puerarin using microemulsion vehicle. Drug Dev Ind Pharm, 35:138-44.
13. Baroli B, Lopez-Quintela MA, Delgado-Charro MB, Fadda AM, Blanco-Mendez J. (2000). Microemulsions for topical delivery of 8-methoxsalen. J Control Release, 69:209-18.
14. Peira E, Scolari P, Gasco MR. (2001). Transdermal permeation of apomorphine through hairless mouse skin from microemulsions. Int J Pharm, 226:47-51.
15. Chen H, Chang X, Weng T, Zhao X, Gao Z, Yang Y, et al. (2004). A study of microemulsion systems for transdermal delivery of triptolide. J Control Release, 98:427-36.
16. Tsai YH, Lee KF, Huang YB, Huang CT, Wu PC. (2010). In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system. Int J Pharm, 388:257-62.
17. Wu PC, Huang YB, Sung CH, Wang RJ, Tsai YH. (2006). The effect of Eudragit and enteric polymer composite on the release of nicardipine. J Food Drug Anal, 14:334-9.
18. Wu H, Ramachandran C, Weiner ND, Roessler BJ. (2001). Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int J Pharm, 220:63-75.
19. Aboofazeli R, Lawrence CB, Wicks SR, Lawrence MJ. (1994). Investigations into the formation and characterisation of phospholipid microemulsions: III. Pseudo-ternary phase diagrams of systems containing water-lecithin-isopropyl myristate and either an alkanoic acid, amine, alkanediol, polyoxyethylene glycol alkyl ether or alcohol as cosurfactant. Int J Pharm, 111:63-72.
20. Trotta M, Gallarate M, Pattarino F, Carlotti ME. (1999). Investigation of the phase behaviour of systems containing lecithin and 2-acyl lysolecithin derivatives. Int J Pharm, 190:83-9.
21. Shah RB, Zidan AS, Funck T, Tawakkul MA, Nguyenpho A, Khan MA. (2007). Quality by design: Characterization of selfnano- emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm, 341:189-94.
22. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. (2007). Quality by design: Understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. Int J Pharm, 332:55-63.
23. Teichmann A, Heuschkel S, Jacobi U, Presse G, Neubert RH, Sterry W, et al. (2007). Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm, 67:699-706.
24. Rhee YS, Choi JG, Park ES, Chi SC. (2001). Transdermal delivery of ketoprofen using microemulsions. Int J Pharm, 228:161-70.
25. Lopez A, Llinares F, Cortell C, Herraez M. (2000). Comparative enhancer effects of Span20 with Tween20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm, 202:133-40.
26. Krishnaiah YS, Satyanarayana V, Bhaskar P. (2003). Influence of menthol and pressure-sensitive adhesives on the in vivo performance of membrane-moderated transdermal therapeutic system of nicardipine hydrochloride in human volunteers. Eur J Pharm Biopharm, 55:329-37.
27. Rhoche Lab.Inc. (2000). Production Information: Cardene® SR (Nicardipine Hydrochloride). Roche Laboratories Inc., 340 Kingsland Street, Nutley, New Jersey 07110-1199. http://www.rxlist.com/cardene-drug.htm [accessed May 10, 2009].